DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 966 filers reported holding DANAHER CORPORATION in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $16,863,000 | -12.9% | 116,760 | -13.8% | 0.58% | -15.3% |
| Q2 2019 | $19,370,000 | +14.9% | 135,531 | +6.2% | 0.69% | -5.5% |
| Q1 2019 | $16,853,000 | +28.1% | 127,658 | +0.1% | 0.73% | -7.5% |
| Q4 2018 | $13,154,000 | -4.9% | 127,558 | +0.2% | 0.79% | +16.3% |
| Q3 2018 | $13,830,000 | -8.3% | 127,282 | -16.7% | 0.68% | -10.4% |
| Q2 2018 | $15,075,000 | +10.1% | 152,767 | +9.2% | 0.76% | -20.3% |
| Q1 2018 | $13,694,000 | +5.5% | 139,860 | +0.1% | 0.95% | +17.1% |
| Q4 2017 | $12,975,000 | +3.4% | 139,786 | -4.5% | 0.81% | +14.2% |
| Q3 2017 | $12,554,000 | -5.8% | 146,357 | -7.3% | 0.71% | -1.2% |
| Q2 2017 | $13,321,000 | -1.3% | 157,857 | 0.0% | 0.72% | +4.2% |
| Q1 2017 | $13,501,000 | -11.6% | 157,857 | -19.5% | 0.69% | -23.7% |
| Q4 2016 | $15,266,000 | +23.4% | 196,126 | +24.2% | 0.91% | -8.8% |
| Q3 2016 | $12,374,000 | -4.6% | 157,857 | +3.2% | 0.99% | +82.2% |
| Q2 2016 | $12,972,000 | -74.7% | 152,897 | -71.7% | 0.54% | -68.8% |
| Q1 2016 | $51,251,000 | -8.0% | 540,274 | -10.0% | 1.74% | -1.4% |
| Q4 2015 | $55,728,000 | -6.6% | 600,000 | -14.3% | 1.77% | +33.9% |
| Q3 2015 | $59,647,000 | -0.4% | 700,000 | 0.0% | 1.32% | +10.9% |
| Q2 2015 | $59,913,000 | +0.8% | 700,000 | 0.0% | 1.19% | -1.7% |
| Q1 2015 | $59,430,000 | -0.9% | 700,000 | 0.0% | 1.21% | -2.9% |
| Q4 2014 | $59,998,000 | +12.8% | 700,000 | 0.0% | 1.25% | +3.0% |
| Q3 2014 | $53,186,000 | -3.5% | 700,000 | 0.0% | 1.21% | -1.9% |
| Q2 2014 | $55,111,000 | -8.1% | 700,000 | -12.5% | 1.24% | -5.1% |
| Q1 2014 | $60,000,000 | -2.8% | 800,000 | 0.0% | 1.30% | -4.8% |
| Q4 2013 | $61,760,000 | +11.4% | 800,000 | 0.0% | 1.37% | +1.9% |
| Q3 2013 | $55,456,000 | +9.5% | 800,000 | 0.0% | 1.34% | +1.8% |
| Q2 2013 | $50,640,000 | – | 800,000 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |